Disregulated expression of EGFR occurs in approximately 40% of glioblastoma patients, and its mutation, EGFRvIII, reaches 20 to 30% of glioblastoma (Riemenschneider et al. 2010). This evidence concerns the gene EGFR and glioblastoma.